Co-Authors
This is a "connection" page, showing publications co-authored by Patricia Boyle and Julie Schneider.
Connection Strength
4.347
-
Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology. 2015 Dec 01; 85(22):1930-6.
Score: 0.466
-
To what degree is late life cognitive decline driven by age-related neuropathologies? Brain. 2021 08 17; 144(7):2166-2175.
Score: 0.174
-
Association of Amyloid-? Pathology with Decision Making and Scam Susceptibility. J Alzheimers Dis. 2021; 83(2):879-887.
Score: 0.167
-
Limbic-predominant Age-related TDP-43 Encephalopathy and Distinct Longitudinal Profiles of Domain-specific Literacy. Alzheimer Dis Assoc Disord. 2020 Oct-Dec; 34(4):299-305.
Score: 0.164
-
Late-life cognitive decline is associated with hippocampal volume, above and beyond its associations with traditional neuropathologic indices. Alzheimers Dement. 2020 01; 16(1):209-218.
Score: 0.155
-
Association of TDP-43 Pathology With Domain-specific Literacy in Older Persons. Alzheimer Dis Assoc Disord. 2019 Oct-Dec; 33(4):315-320.
Score: 0.153
-
Common age-related neuropathologies and yearly variability in cognition. Ann Clin Transl Neurol. 2019 11; 6(11):2140-2149.
Score: 0.153
-
Postmortem neurodegenerative markers and trajectories of decline in cognitive systems. Neurology. 2019 02 19; 92(8):e831-e840.
Score: 0.146
-
Cognitive decline after elective and nonelective hospitalizations in older adults. Neurology. 2019 02 12; 92(7):e690-e699.
Score: 0.145
-
Attributable risk of Alzheimer's dementia attributed to age-related neuropathologies. Ann Neurol. 2019 01; 85(1):114-124.
Score: 0.145
-
Watershed microinfarct pathology and cognition in older persons. Neurobiol Aging. 2018 10; 70:10-17.
Score: 0.139
-
Postmortem brain MRI is related to cognitive decline, independent of cerebral vessel disease in older adults. Neurobiol Aging. 2018 09; 69:177-184.
Score: 0.139
-
TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer's disease. Acta Neuropathol Commun. 2018 05 01; 6(1):33.
Score: 0.138
-
Neurodegenerative disease and cognitive retest learning. Neurobiol Aging. 2018 06; 66:122-130.
Score: 0.138
-
Person-specific contribution of neuropathologies to cognitive loss in old age. Ann Neurol. 2018 01; 83(1):74-83.
Score: 0.136
-
Age and the association of dementia-related pathology with trajectories of cognitive decline. Neurobiol Aging. 2018 01; 61:138-145.
Score: 0.132
-
Varied effects of age-related neuropathologies on the trajectory of late life cognitive decline. Brain. 2017 03 01; 140(3):804-812.
Score: 0.128
-
Financial and Health Literacy Predict Incident Alzheimer's Disease Dementia and Pathology. J Alzheimers Dis. 2017; 56(4):1485-1493.
Score: 0.126
-
TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia. Brain. 2016 11 01; 139(11):2983-2993.
Score: 0.125
-
White matter hyperintensities, incident mild cognitive impairment, and cognitive decline in old age. Ann Clin Transl Neurol. 2016 10; 3(10):791-800.
Score: 0.123
-
Postmortem MRI: a novel window into the neurobiology of late life cognitive decline. Neurobiol Aging. 2016 09; 45:169-177.
Score: 0.121
-
Temporal course of neurodegenerative effects on cognition in old age. Neuropsychology. 2016 07; 30(5):591-9.
Score: 0.120
-
Temporal course and pathologic basis of unawareness of memory loss in dementia. Neurology. 2015 Sep 15; 85(11):984-91.
Score: 0.115
-
APOE and cerebral amyloid angiopathy in community-dwelling older persons. Neurobiol Aging. 2015 Nov; 36(11):2946-2953.
Score: 0.115
-
Relation of neuropathology with cognitive decline among older persons without dementia. Front Aging Neurosci. 2013; 5:50.
Score: 0.100
-
Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies. Brain. 2012 Oct; 135(Pt 10):3005-14.
Score: 0.094
-
Relative Contributions of Mixed Pathologies to Cognitive and Functional Symptoms in Brain Donors Exposed to Repetitive Head Impacts. Ann Neurol. 2023 Nov 03.
Score: 0.051
-
Longitudinal change in serial position scores in older adults with entorhinal and hippocampal neuropathologies. J Int Neuropsychol Soc. 2023 Jul; 29(6):561-571.
Score: 0.047
-
Genetic Evidence Supporting a Causal Role of Depression in Alzheimer's Disease. Biol Psychiatry. 2022 07 01; 92(1):25-33.
Score: 0.045
-
Association of serial position scores on memory tests and hippocampal-related neuropathologic outcomes. Neurology. 2020 12 15; 95(24):e3303-e3312.
Score: 0.041
-
Alzheimer's disease frequency peaks in the tenth decade and is lower afterwards. Acta Neuropathol Commun. 2019 07 03; 7(1):104.
Score: 0.038
-
Association Between Brain Gene Expression, DNA Methylation, and Alteration of Ex Vivo Magnetic Resonance Imaging Transverse Relaxation in Late-Life Cognitive Decline. JAMA Neurol. 2017 12 01; 74(12):1473-1480.
Score: 0.034
-
Neuropathologic correlates of regional brain volumes in a community cohort of older adults. Neurobiol Aging. 2015 Oct; 36(10):2798-805.
Score: 0.028
-
Effect of common neuropathologies on progression of late life cognitive impairment. Neurobiol Aging. 2015 Jul; 36(7):2225-2231.
Score: 0.028
-
Purpose in life and cerebral infarcts in community-dwelling older people. Stroke. 2015 Apr; 46(4):1071-6.
Score: 0.028
-
Residual decline in cognition after adjustment for common neuropathologic conditions. Neuropsychology. 2015 May; 29(3):335-43.
Score: 0.027
-
Brain pathology contributes to simultaneous change in physical frailty and cognition in old age. J Gerontol A Biol Sci Med Sci. 2014 Dec; 69(12):1536-44.
Score: 0.027
-
Life-span cognitive activity, neuropathologic burden, and cognitive aging. Neurology. 2013 Jul 23; 81(4):314-21.
Score: 0.025
-
APOE e4, Alzheimer's disease pathology, cerebrovascular disease, and cognitive change over the years prior to death. Psychol Aging. 2013 Dec; 28(4):1015-23.
Score: 0.024
-
Microvascular brain pathology and late-life motor impairment. Neurology. 2013 Feb 19; 80(8):712-8.
Score: 0.024
-
Antiphospholipid antibodies, brain infarcts, and cognitive and motor decline in aging (ABICMA): design of a community-based, longitudinal, clinical-pathological study. Neuroepidemiology. 2013; 40(2):73-84.
Score: 0.024